Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravesical Botulinum Toxin Type A for Urge Incontinence
NCT00770406Phase 2Unknown
- Sponsor
- Rigshospitalet Glostrup
- Start
- Jan 2009
- Primary completion
- Jun 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of botulinum toxin type A in urge urinary incontinence (UUI), sponsored by Rigshospitalet Glostrup. Status: unknown.
02
Drugs
botulinum toxin type A
03
Conditions
urge urinary incontinence (UUI)
Beyond the preview
Go deeper on NCT00770406.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770406.